Atara Biotherapeutics, Inc.: Form DEF 14A, filed Apr 24, 2026
Filed with the SEC on Apr 24, 2026 and accepted by EDGAR at Apr 24, 2026, 16:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-177285. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.